Jim Simons
NMTC icon

Jim Simons’s NeuroOne Medical Technologies NMTC Stock Holding History

Jim Simons’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Sell
70,861
-38,380
-35% -$157K ﹤0.01% 2867
2026
Q1 		$509K Sell
109,241
-17,930
-14% -$86.1K ﹤0.01% 2592
2025
Q4 		$578K Buy
127,171
+11,738
+10% +$53.5K ﹤0.01% 2516
2025
Q3 		$615K Buy
115,433
+37,283
+48% +$183K ﹤0.01% 2706
2025
Q2 		$318K Buy
+78,150
New +$289K ﹤0.01% 3022

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Jim Simons's NMTC Position: Q2 2026 in Review

Jim Simons reduced its NeuroOne Medical Technologies (NMTC) stake by 35% in Q2 2026, selling an estimated $157K and leaving 70,861 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #2867.

Jim Simons first reported a position in NMTC in Q2 2025 and has held it in 5 quarters since. The position peaked at $615K in Q3 2025. 20 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Jim Simons held 70,861 shares of NeuroOne Medical Technologies worth $215K as of Q2 2026.
  • Jim Simons sold 38,380 NeuroOne Medical Technologies shares in Q2 2026, an estimated $157K.
  • NeuroOne Medical Technologies made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2867 holding.
  • Jim Simons first reported a position in NeuroOne Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • Jim Simons's NeuroOne Medical Technologies position peaked at $615K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.